From mechanisms to management: translating the neuropathic pain consensus recommendations into clinical practice.

Title

From mechanisms to management: translating the neuropathic pain consensus recommendations into clinical practice.

Creator

Chevlen E; Davies PS; Rhiner M

Publisher

Journal of the American Academy of Nurse Practitioners

Date

2005
2005-06-02

Description

Chronic neuropathic pain poses a treatment challenge, and is associated with significant psychologic distress, physical disability, and impaired functioning, which impact the activities of daily living. Efforts to provide relief are often inadequate and/or require polypharmacy. This has spurred interest among researchers and clinicians alike to develop early, intensive treatments that target the molecular and cellular mechanisms involved in pain transduction, transmission, and modulation, or ideally, that prevent neuropathic pain from occurring in the first place. Currently, researchers are attempting to capitalize on our understanding of neuropathic pain pathophysiology to develop drugs that interrupt distinct activities involved in its perpetuation. In this regard, several potential agents (eg, NMDA and AMPA/kainate antagonists) are in phase 2 and 3 clinical trials. In the interim, evolving data and evidence-based neuropathic treatment recommendations provide guidance for selecting first- and second-line medications that alone or in combination offer acceptable neuropathic pain control and allow clinicians to bridge the gap between current knowledge and its application in the clinical setting. Hopefully, as basic and clinical science progresses, further treatment advances and management tools will be found to improve the care of patients who live with neuropathic pain.

Subject

Adult; Female; Aged; Inflammation; Pain Measurement; Comorbidity; Education; Neoplasm Metastasis; Drugs; Perception; Clinical Trials; Middle Age; Sarcoidosis; Analgesics; Drug Therapy; Combination; Antidepressive Agents; Treatment Outcomes; Cancer Patients; Chronic Pain; Treatment Duration; Breast Neoplasms; Visual Analog Scaling; Lung Neoplasms; Melanoma; Rectal Neoplasms; Continuing (Credit); Transdermal Patches; Lidocaine – Administration and Dosage; Analgesics – Administration and Dosage; Analgesics – Adverse Effects; Cytokines – Physiology; Gabapentin – Administration and Dosage; Neural Transmission – Physiology; Neuralgia – Classification; Neuralgia – Drug Therapy; Neuralgia – Physiopathology; Opioid – Administration and Dosage; Peripheral Nervous System – Physiopathology; Tramadol – Administration and Dosage; Tricyclic – Administration and Dosage

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Pages

4–20

Volume

17

Citation

Chevlen E; Davies PS; Rhiner M, “From mechanisms to management: translating the neuropathic pain consensus recommendations into clinical practice.,” NEOMED Bibliography Database, accessed October 28, 2021, https://neomed.omeka.net/items/show/6097.

Social Bookmarking